Spatially resolved mapping of histones reveals selective neuronal response in Rett syndrome
The FEBS Journal · 2026
DOI: 10.1111/febs.70534 ↗At a glance
Journal article in The FEBS Journal, 2026. Written by Frederike Schäfer and 6 co-authors. Institution: Biomedical Center Munich, Department of Molecular Biology, Faculty of Medicine, Ludwig-Maximilians Universität München, Planegg-Martinsried, Germany. Major MEDLINE topics: Rett Syndrome, Histones, Methyl-CpG-Binding Protein 2, Neurons. Cited 1 times so far (Crossref); 106 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft, proRETT, Forschungsmodul Medizin program of the Medical Faculty.
Abstract (original language)
Rett syndrome (RTT), a severe neurological disorder caused by loss‐of‐function mutations in the X‐linked Mecp2 gene, results in profound life‐long neurological dysfunction. Rett syndrome patients live an apparently normal initial life until 12–18 months of age, after which a progressive accumulation of a wide range of phenotypic manifestations sets in. While MeCP2 is known to regulate chromatin, its impact on global histone composition and dynamics remains poorly understood. Here, we combine mass spectrometry imaging (MSI) and laser capture microdissection (LCM) coupled to LC–MS/MS to systematically profile histone proteoforms in three key brain regions: the dentate gyrus (DG) and cornu ammonis (CA) of the hippocampus, and the cerebellum (Cb). Our analysis reveals striking neuron‐specific differences in histone composition between Mecp2‐deficient and wild‐type (WT) mice. Interestingly, the expression of a pathogenic Mecp2 missense mutant (Y120D) results in subtler changes in histone composition that are distinct from the null mutation. This study provides the first spatially resolved epigenetic atlas of histone proteoforms in Rett syndrome and suggests that Mecp2 loss perturbs chromatin homeostasis in a neuron‐ and mutation‐dependent manner. Our findings underscore the critical need for cell‐type‐resolved analyses to unravel the mechanistic underpinnings of Rett syndrome and emphasize the importance of personalized therapeutic strategies that consider both the affected cell type and particular Mecp2 mutation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Biomedical Center Munich, Department of Molecular Biology, Faculty of Medicine, Ludwig-Maximilians Universität München, Planegg-Martinsried, Germany.
- San Raffaele Rett Research Unit, Neuroscience Division, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Department of Medical Biotechnology and Translational Medicine, Faculty of Medicine, University of Milan, Italy.
- MoleQlar Analytics GmbH, München, Germany.
- Biomedical Center Munich, Protein Analysis Unit (ZfP), Faculty of Medicine, Ludwig-Maximilians Universität München, Planegg-Martinsried, Germany.
ORCID profiles: Axel Imhof, Shibojyoti Lahiri
Funding
- Deutsche Forschungsgemeinschaft
- proRETT
- Forschungsmodul Medizin program of the Medical Faculty
- SCALE-UP project of the Department of Medical Biotechnology and Translational Medicine
Cite
APA
Schäfer, F., De Rocco, G., Völker-Albert, M., Forne, I., Landsberger, N., Imhof, A., & Lahiri, S. (2026). Spatially resolved mapping of histones reveals selective neuronal response in Rett syndrome. The FEBS Journal. https://doi.org/10.1111/febs.70534
Vancouver
Schäfer F, De Rocco G, Völker-Albert M, Forne I, Landsberger N, Imhof A, et al. Spatially resolved mapping of histones reveals selective neuronal response in Rett syndrome. The FEBS Journal. 2026. doi:10.1111/febs.70534
BibTeX
@article{Schfer2026,
author = {Schäfer, Frederike and De Rocco, Giuseppina and Völker-Albert, Moritz and Forne, Ignasi and Landsberger, Nicoletta and Imhof, Axel and Lahiri, Shibojyoti},
title = {Spatially resolved mapping of histones reveals selective neuronal response in Rett syndrome},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70534}
}
EUVIMED